1. Home
  2. RCKT vs NXRT Comparison

RCKT vs NXRT Comparison

Compare RCKT & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • NXRT
  • Stock Information
  • Founded
  • RCKT 1999
  • NXRT 2014
  • Country
  • RCKT United States
  • NXRT United States
  • Employees
  • RCKT N/A
  • NXRT N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • NXRT Real Estate Investment Trusts
  • Sector
  • RCKT Health Care
  • NXRT Real Estate
  • Exchange
  • RCKT Nasdaq
  • NXRT Nasdaq
  • Market Cap
  • RCKT 1.3B
  • NXRT 1.2B
  • IPO Year
  • RCKT N/A
  • NXRT N/A
  • Fundamental
  • Price
  • RCKT $11.74
  • NXRT $43.49
  • Analyst Decision
  • RCKT Strong Buy
  • NXRT Buy
  • Analyst Count
  • RCKT 11
  • NXRT 5
  • Target Price
  • RCKT $50.27
  • NXRT $49.00
  • AVG Volume (30 Days)
  • RCKT 1.3M
  • NXRT 91.8K
  • Earning Date
  • RCKT 11-07-2024
  • NXRT 02-18-2025
  • Dividend Yield
  • RCKT N/A
  • NXRT 4.52%
  • EPS Growth
  • RCKT N/A
  • NXRT 54.64
  • EPS
  • RCKT N/A
  • NXRT 1.77
  • Revenue
  • RCKT N/A
  • NXRT $264,974,000.00
  • Revenue This Year
  • RCKT N/A
  • NXRT N/A
  • Revenue Next Year
  • RCKT $234,928.88
  • NXRT $0.54
  • P/E Ratio
  • RCKT N/A
  • NXRT $25.24
  • Revenue Growth
  • RCKT N/A
  • NXRT N/A
  • 52 Week Low
  • RCKT $11.58
  • NXRT $28.20
  • 52 Week High
  • RCKT $32.53
  • NXRT $48.37
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 27.69
  • NXRT 43.52
  • Support Level
  • RCKT $11.58
  • NXRT $44.31
  • Resistance Level
  • RCKT $15.00
  • NXRT $46.15
  • Average True Range (ATR)
  • RCKT 0.82
  • NXRT 0.90
  • MACD
  • RCKT -0.09
  • NXRT -0.30
  • Stochastic Oscillator
  • RCKT 4.65
  • NXRT 14.08

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

Share on Social Networks: